תוצאות חיפוש - Kathleen M. Darcy

Refine Results
  1. 1
    Knockdown of splicing factor SRp20 causes apoptosis in ovarian cancer cells and its expression is associated with malignancy of epithelial ovarian cancer

    Knockdown of splicing factor SRp20 causes apoptosis in ovarian cancer cells and its expression is associated with malignancy of epithelial ovarian cancer מאת Xijing He, Ahmet Arslan, Mark Pool, T-T Ho, Kathleen M. Darcy, John S. Coon, William T. Beck

    יצא לאור 2010
    קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  2. 2
    Knockdown of polypyrimidine tract-binding protein suppresses ovarian tumor cell growth and invasiveness in vitro

    Knockdown of polypyrimidine tract-binding protein suppresses ovarian tumor cell growth and invasiveness in vitro מאת Xijing He, Mark Pool, Kathleen M. Darcy, S B Lim, Nelly Auersperg, John S. Coon, William T. Beck

    יצא לאור 2007
    קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  3. 3
    Current Approaches and Challenges in Managing and Monitoring Treatment Response in Ovarian Cancer

    Current Approaches and Challenges in Managing and Monitoring Treatment Response in Ovarian Cancer מאת Charlotte Marcus, G. Larry Maxwell, Kathleen M. Darcy, Chad A. Hamilton, William P. McGuire

    יצא לאור 2014
    קבל טקסט מלא קבל טקסט מלא
    Revisão
    הוספה למועדפים
    שמור ב:
  4. 4
    A phase II trial of thalidomide in patients with refractory endometrial cancer and correlation with angiogenesis biomarkers: A Gynecologic Oncology Group study

    A phase II trial of thalidomide in patients with refractory endometrial cancer and correlation with angiogenesis biomarkers: A Gynecologic Oncology Group study מאת D. Scott McMeekin, Michael W. Sill, Doris M. Benbrook, Kathleen M. Darcy, Deborah J. Stearns-Kurosawa, Lynne Eaton, S. Diane Yamada

    יצא לאור 2007
    קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  5. 5
    Pharmacologic inhibition of ATR and ATM offers clinically important distinctions to enhancing platinum or radiation response in ovarian, endometrial, and cervical cancer cells

    Pharmacologic inhibition of ATR and ATM offers clinically important distinctions to enhancing platinum or radiation response in ovarian, endometrial, and cervical cancer cells מאת Pang-ning Teng, Nicholas W. Bateman, Kathleen M. Darcy, Chad A. Hamilton, G. Larry Maxwell, Christopher J. Bakkenist, Thomas P. Conrads

    יצא לאור 2015
    קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  6. 6
    Phase III trial to evaluate the efficacy of maintaining hemoglobin levels above 12.0 g/dL with erythropoietin vs above 10.0 g/dL without erythropoietin in anemic patients receiving concurrent radiation and cisplatin for cervical cancer

    Phase III trial to evaluate the efficacy of maintaining hemoglobin levels above 12.0 g/dL with erythropoietin vs above 10.0 g/dL without erythropoietin in anemic patients receiving... מאת Gillian Thomas, Shamshad Ali, Frank Hoebers, Kathleen M. Darcy, William H. Rodgers, Malti Patel, O. Abulafia, Joseph A. Lucci, Adrian C. Begg

    יצא לאור 2007
    קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  7. 7
    Relationship Between<i>ERCC1</i>Polymorphisms, Disease Progression, and Survival in the Gynecologic Oncology Group Phase III Trial of Intraperitoneal Versus Intravenous Cisplatin and Paclitaxel for Stage III Epithelial Ovarian Cancer

    Relationship Between<i>ERCC1</i>Polymorphisms, Disease Progression, and Survival in the Gynecologic Oncology Group Phase III Trial of Intraperitoneal Versus Intravenous Cisplatin a... מאת Thomas C. Krivak, Kathleen M. Darcy, Chunqiao Tian, Deborah K. Armstrong, Bora Baysal, Holly H. Gallion, Christine B. Ambrosone, Julie A. DeLoia

    יצא לאור 2008
    קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  8. 8
    High glucocorticoid receptor expression predicts short progression-free survival in ovarian cancer

    High glucocorticoid receptor expression predicts short progression-free survival in ovarian cancer מאת Jennifer Veneris, Kathleen M. Darcy, Paulette Mhawech‐Fauceglia, Chunqiao Tian, Ernst Lengyel, Ricardo R. Lastra, Tanja Pejović, Suzanne D. Conzen, Gini F. Fleming

    יצא לאור 2017
    קבל טקסט מלא קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  9. 9
    Trends in Uterine Cancer Mortality in the United States

    Trends in Uterine Cancer Mortality in the United States מאת Sahana Somasegar, Aya Bashi, Susan M. Lang, Cheng-I Liao, C. A. Johnson, Kathleen M. Darcy, Chunqiao Tian, Daniel S. Kapp, John K. Chan

    יצא לאור 2023
    קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  10. 10
    BRCA1 expression and improved survival in ovarian cancer patients treated with intraperitoneal cisplatin and paclitaxel: a Gynecologic Oncology Group Study

    BRCA1 expression and improved survival in ovarian cancer patients treated with intraperitoneal cisplatin and paclitaxel: a Gynecologic Oncology Group Study מאת Jamie Lesnock, Kathleen M. Darcy, Chunqiao Tian, Julie A. DeLoia, Melissa M. Thrall, Chris Zahn, Deborah K. Armstrong, Michael J. Birrer, Thomas C. Krivak

    יצא לאור 2013
    קבל טקסט מלא קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  11. 11
    Markers of angiogenesis in high-risk, early-stage cervical cancer: A Gynecologic Oncology Group study

    Markers of angiogenesis in high-risk, early-stage cervical cancer: A Gynecologic Oncology Group study מאת Leslie M. Randall, Bradley J. Monk, Kathleen M. Darcy, Chunqiao Tian, Robert A. Burger, Shu‐Yuan Liao, William A. Peters, Richard J. Stock, John P. Fruehauf

    יצא לאור 2008
    קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  12. 12
    Phase II Study of Gefitinib in Patients with Relapsed or Persistent Ovarian or Primary Peritoneal Carcinoma and Evaluation of Epidermal Growth Factor Receptor Mutations and Immunohistochemical Expression: A Gynecologic Oncology Group Study

    Phase II Study of Gefitinib in Patients with Relapsed or Persistent Ovarian or Primary Peritoneal Carcinoma and Evaluation of Epidermal Growth Factor Receptor Mutations and Immunoh... מאת Russell J. Schilder, Michael W. Sill, Xiaowei Chen, Kathleen M. Darcy, Steven DeCesare, George Lewandowski, Roger B. Lee, Cletus Arciero, Hong Wu, Andrew K. Godwin

    יצא לאור 2005
    קבל טקסט מלא קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  13. 13
    Phase II trial of the mTOR inhibitor, temsirolimus and evaluation of circulating tumor cells and tumor biomarkers in persistent and recurrent epithelial ovarian and primary peritoneal malignancies: A Gynecologic Oncology Group study

    Phase II trial of the mTOR inhibitor, temsirolimus and evaluation of circulating tumor cells and tumor biomarkers in persistent and recurrent epithelial ovarian and primary periton... מאת Kian Behbakht, Michael W. Sill, Kathleen M. Darcy, Stephen C. Rubin, Robert S. Mannel, Steven Waggoner, Russell J. Schilder, Kathy Q. Cai, Andrew K. Godwin, R. Katherine Alpaugh

    יצא לאור 2011
    קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  14. 14
    Phase II Trial of Bevacizumab in Recurrent or Persistent Endometrial Cancer: A Gynecologic Oncology Group Study

    Phase II Trial of Bevacizumab in Recurrent or Persistent Endometrial Cancer: A Gynecologic Oncology Group Study מאת Carol Aghajanian, Michael W. Sill, Kathleen M. Darcy, Benjamin E. Greer, D. Scott McMeekin, Peter G. Rose, Jacob Rotmensch, Mack N. Barnes, Parviz Hanjani, Kimberly K. Leslie

    יצא לאור 2011
    קבל טקסט מלא קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  15. 15
    Prognostic relevance of carbonic anhydrase-IX in high-risk, early-stage cervical cancer: A Gynecologic Oncology Group study

    Prognostic relevance of carbonic anhydrase-IX in high-risk, early-stage cervical cancer: A Gynecologic Oncology Group study מאת Shu‐Yuan Liao, Kathleen M. Darcy, Leslie M. Randall, Chunqiao Tian, Bradley J. Monk, Robert A. Burger, John P. Fruehauf, William A. Peters, Richard J. Stock, Eric J. Stanbridge

    יצא לאור 2009
    קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  16. 16
    Phase II trial of trastuzumab in women with advanced or recurrent, HER2-positive endometrial carcinoma: A Gynecologic Oncology Group study

    Phase II trial of trastuzumab in women with advanced or recurrent, HER2-positive endometrial carcinoma: A Gynecologic Oncology Group study מאת Gini F. Fleming, Michael W. Sill, Kathleen M. Darcy, D. Scott McMeekin, J.T. Thigpen, Lisa Adler, Jonathan S. Berek, Julia Chapman, Paul DiSilvestro, Ira Horowitz, James V. Fiorica

    יצא לאור 2009
    קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  17. 17
    Randomized phase III trial of tamoxifen versus thalidomide in women with biochemical-recurrent-only epithelial ovarian, fallopian tube or primary peritoneal carcinoma after a complete response to first-line platinum/taxane chemotherapy with an evaluation of serum vascular endothelial growth factor (VEGF): A Gynecologic Oncology Group Study

    Randomized phase III trial of tamoxifen versus thalidomide in women with biochemical-recurrent-only epithelial ovarian, fallopian tube or primary peritoneal carcinoma after a compl... מאת Jean Hurteau, Mark F. Brady, Kathleen M. Darcy, William P. McGuire, Pamela Edmonds, Michael L. Pearl, I. I. Ivanov, Krishnansu S. Tewari, Robert S. Mannel, Kristine Zanotti, Doris M. Benbrook

    יצא לאור 2010
    קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  18. 18
    Common variants in ABCB1, ABCC2 and ABCG2 genes and clinical outcomes among women with advanced stage ovarian cancer treated with platinum and taxane-based chemotherapy: A Gynecologic Oncology Group study

    Common variants in ABCB1, ABCC2 and ABCG2 genes and clinical outcomes among women with advanced stage ovarian cancer treated with platinum and taxane-based chemotherapy: A Gynecolo... מאת Chunqiao Tian, Christine B. Ambrosone, Kathleen M. Darcy, Thomas C. Krivak, Deborah K. Armstrong, Michael A. Bookman, Warren Davis, Hua Zhao, Kirsten B. Moysich, Holly H. Gallion, Julie A. DeLoia

    יצא לאור 2011
    קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  19. 19
    NUAK1 (ARK5) Is Associated with Poor Prognosis in Ovarian Cancer

    NUAK1 (ARK5) Is Associated with Poor Prognosis in Ovarian Cancer מאת Neil T. Phippen, Nicholas W. Bateman, Guisong Wang, Kelly A. Conrads, Wei Ao, Pang-ning Teng, Tracy Litzi, Julie Oliver, G. Larry Maxwell, Chad A. Hamilton, Kathleen M. Darcy, Thomas P. Conrads

    יצא לאור 2016
    קבל טקסט מלא קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  20. 20
    A phase II evaluation of gefitinib in the treatment of persistent or recurrent endometrial cancer: A Gynecologic Oncology Group study

    A phase II evaluation of gefitinib in the treatment of persistent or recurrent endometrial cancer: A Gynecologic Oncology Group study מאת Kimberly K. Leslie, Michael W. Sill, Edgar Fischer, Kathleen M. Darcy, Robert S. Mannel, Krishnansu S. Tewari, Parviz Hanjani, Jason A. Wilken, Andre T. Baron, Andrew K. Godwin, Russell J. Schilder, Meenakshi Singh, Nita J. Maihle

    יצא לאור 2013
    קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:

כלי חיפוש: